Skip to content

Drug Developer's Intelligence Report

Oncology DRUG REPORT

2021

Two Reports providing complete landscape on oncology drug development

2010

Oncology Drug Developers Worldwide

ODR 2021 is a set of Two Reports and provides Complete Solution to Identify & Connect with Largest Number of Active Oncology Drug Development Companies.

oncology Drug intelligence - 2021 (Sixth Updated Edition)

Report Covers all Aspects of Cancer Drug Development Intelligence

COMPANIES * MOLECULES * INDICATIONS * TECHNOLOGIES * DEALS * FUNDING

Oncology drug intelligence 2021
largest coverage

providing intelligence at fingertips

Countries
1

Worldwide 34 Countries Covered. Largest Coverage Guaranteed

Drug developers
1

1009 Active Clinical & 1001 Preclinical Stage Oncology Companies Profiled 

Molecules in Development
1 +

Individual Drug Mechanism of Action & Drug Target

Cancer Targets
1 +

Covers complete Emerging Cancer Drug Targets Details with Numerous Technologies

TWO REPORTS

Intelligence @ fingertips

Provides Complete Landscape on Latest Oncology Drug Development covering Emerging Technologies, Partnering and Funding Status in the Domain.
Drug Developers with proper funding, technologies and pipeline are only included.
No Acquired, Merged or Dormant Stage Cancer Targeting Drug Developer is included.

01

identify new opportunities

TWO Oncology reports

360 Degree Insights on Drug Development

  • 2000+ Active Cancer Drug Developers.
  • 3500+ Active Molecules in Development.
  • 1400+ Deals & Partnering Details.
  • Special coverage on CAR-T, Vaccines, ADCs, Monoclonal Antibodies, Oncolytic Viruses and Small molecule Kinase Inhibitors.
  • Emerging Technologies like Microbiome, CRISPER, Exosomes, RNAi etc., as Cancer treatment are covered.

Perfect B2B Solution

Unique first in class Intelligence Report

Trusted by

BUSINESS LEADERS -WORLDWIDE